Last Updated: 16/02/2024

Alpha-PBO LLIN Phase I and Phase II Support

Objectives

To produce Phase I and Phase II data for evaluation of a new alphacypermethrin-PBO LLIN

Principal Institution

Ifakara Health Institute (IHI), Tanzania

External reference

Project details

Thematic Categories

Information Systems
Vector Control

Date

Aug 2020 — Sep 2022

Total Project Funding

$250,291

Funding Details
Gates Foundation (GF), United States

INV-022988
Project Site

Tanzania

SHARE

Related Resources

ASTMH 2019, Tatiana Sandrine Hountohotegbe: “Memory B and functional anti body responses to the PAMVAC vaccine candidate during Phase Ib clinical trial in Benin”
Multimedia
Malaria Minute Podcast: Mosquito Saliva Vaccine Evaluated in Phase 1 Trial
Multimedia
Eliminating malaria (case study 10): Successful elimination and prevention of re-establishment of malaria in Tunisia

Related Projects

Oct 2020 —
Sep 2022

$100,217

Alpha-PBO LLIN Phase II Support
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
SHARE